Phase I, Open-Label, Randomized, Single Sequence Study With Two Dose Groups to Compare the Pharmacokinetics of BMS-927711 in Migraine Subjects During an Acute Migraine Attack and During Non-Migraine Period.

Trial Profile

Phase I, Open-Label, Randomized, Single Sequence Study With Two Dose Groups to Compare the Pharmacokinetics of BMS-927711 in Migraine Subjects During an Acute Migraine Attack and During Non-Migraine Period.

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Jun 2013

At a glance

  • Drugs Rimegepant (Primary)
  • Indications Migraine with aura; Migraine without aura
  • Focus Pharmacokinetics
  • Most Recent Events

    • 07 Jun 2013 Actual initiation date changed from Jan 2011 to Nov 2011 as reported by ClinicalTrials.gov.
    • 30 Mar 2012 Planned End Date changed from 1 Mar 2012 to 1 Jun 2012 as reported by ClinicalTrials.gov.
    • 15 Feb 2012 Actual initiation date changed from Nov 2011 to Jan 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top